← All stocks

Voyager Therapeutics, Inc.

VYGR No buying or selling
CIK 0001640266 #3912 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

7 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sandrock Alfred
President and CEO
472,549
$1.83M
+43.1%
Swartz Robin
COO & CBO
199,738
$772.99K
+68.1%
Ferguson Toby
Chief Medical Officer
183,914
$711.75K
+75.2%
Jorgensen Nathan D.
Chief Financial Officer
151,416
$585.98K
Carter Todd Alfred
Chief Scientific Officer
145,718
$563.93K
+66.3%
Fahey Sandell Jacquelyn
Chief Legal Officer
123,143
$476.56K
+33.9%
Shiferman Gregory L.
SVP and General Counsel
50,000
$193.50K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Dec 2016